These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy.
    Author: Osuntokun BO, Langman MJ, Wilson J, Aladetoyinbo A.
    Journal: J Neurol Neurosurg Psychiatry; 1970 Oct; 33(5):663-6. PubMed ID: 4920799.
    Abstract:
    The results are presented of a double-blind therapeutic trial of hydroxocobalamin and riboflavine in Nigerian patients suffering from a degenerative neuropathy. Although no benefit from either vitamin was demonstrated, this may reflect the inadequacy of the dosages used. The results are discussed in relation to the hypothesis that dietary cyanide and cyanogens are responsible, at least in part, for the occurrence of this disease in a malnourished population.
    [Abstract] [Full Text] [Related] [New Search]